-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CrzYlqzA8zCxvWcKQzNu6/89ga8xJ5warH0udYJN4+PjKHQR5FtOr1Qf9EpGNVZX y3wb9reFSQ4uXGQra/jBuA== 0001191076-07-000008.txt : 20070927 0001191076-07-000008.hdr.sgml : 20070927 20070927161522 ACCESSION NUMBER: 0001191076-07-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070925 FILED AS OF DATE: 20070927 DATE AS OF CHANGE: 20070927 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HOBDEN ADRIAN N CENTRAL INDEX KEY: 0001191076 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26642 FILM NUMBER: 071139573 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2007-09-25 0 0000899923 MYRIAD GENETICS INC MYGN 0001191076 HOBDEN ADRIAN N 320 WAKARA WAY SALT LAKE CITY UT 84108 0 1 0 0 Pres. Myriad Pharmaceuticals Common Stock 2007-09-25 4 M 0 20000 5.125 A 67236 D Common Stock 2007-09-25 4 S 0 20000 50 D 47236 D Non-Qualified Stock Option (right to buy) 5.125 2007-09-25 4 M 0 20000 50 D 2008-10-21 Common Stock 20000 27464 D This transaction was effected pursuant to a Rule 10b5-1 trading plan. Right to buy non-qualified stock option. 20% vests annually beginning 10/21/99. By: Richard M. Marsh For: Adrian N. Hobden 2007-09-27 -----END PRIVACY-ENHANCED MESSAGE-----